Drug Trial Two PTSD Drug Trials

NYU – Eli Lilly Drug Trial: Back in NYC

Back in my hotel room after a long day and night! I flew in on a redeye and the flight here was crowded and I was squished in my seat by a rather large fellow with a robust snore. At least he slept well. 😉

It was 78 degrees when I left, 10 degrees when I landed. Freaking cold!! But I love it.

I made my way to the hotel, got an early check-in with no problem, and after a good breakfast I popped over to NYU for my follow-up bloodwork and last official visit for the Pfizer drug trial.

Easy peasy, right?

Here’s what I’m headed into – the last great hurrah:

ClinicalTrials.gov: https://clinicaltrials.gov/ct2/show/NCT02234687

To evaluate the effect of 160mg and 40mg challenge of the mGlu2/3 receptor agonist pomaglumetad methionil relative to placebo in mitigating fear-potentiated startle using the neutral-predictable-unpredictable fear-potentiated startle paradigm in adults with post-traumatic stress disorder (PTSD). The primary index of unpredictable fear will be the difference score between startle magnitude in safe and unpredictable conditions in the absence of the cue.

Back to the hotel, and after an awesome, much-needed several hour nap I walked two miles to get one of the best damn Cheesesteaks I’ve ever had.

Now my eyelids are heavy once again, so I’m going to listen to my body and get some more rest.

Related posts

NYU – Pfizer Drug Trial: Day 8: Almost home (for now)


Arterial Line Time


Let The PET Scan Begin


Leave a Comment